Class II
Terminated
Lansoprazole Delayed-Release Capsules, USP, 30 mg, 90-count bottle, Rx Only, Manufactured By: Dr. Reddy's Laboratories Limited, Bachupally - 500 090, India, NDC 55111-399-90.
Why: Failed Dissolution Specifications; during long term stability testing.
- Company
- Dr. Reddy's Laboratories, Inc.
Princeton, NJ, United States - Reported
- Apr 6, 2022
- Recall started
- Mar 23, 2022
- Ended
- Feb 2, 2024
- Where sold
- Nationwide in the USA
- Amount
- 7,703 bottles
- Full product description
- Lansoprazole Delayed-Release Capsules, USP, 30 mg, 90-count bottle, Rx Only, Manufactured By: Dr. Reddy's Laboratories Limited, Bachupally - 500 090, India, NDC 55111-399-90.
- Lots / codes affected
- Lot# C2102911, Exp. 12/2023
Class I: could cause serious harm or death. Class II: could cause temporary or treatable problems. Class III: unlikely to cause harm.